Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

619
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
619
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

613
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
613

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Newly available and recent advances in drug-eluting stents.

Expert review of cardiovascular therapy·2013
Same author

Reply: To PMID 23257375.

JACC. Cardiovascular interventions·2013
Same author

Can bioabsorbable scaffolds be used in calcified lesions?

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2013
Same author

Impact of residual chronic total occlusion of right coronary artery on the long-term outcome in patients treated for unprotected left main disease: the Milan and New-Tokyo registry.

Circulation. Cardiovascular interventions·2013
Same author

[Intra-arterial thrombolysis facilitated by ultrasound in submassive pulmonary embolism: first documented case report in Italy].

Giornale italiano di cardiologia (2006)·2013
Same author

Renal denervation in a patient with two renal accessory arteries: a case report.

Blood pressure·2013

相关实验视频

Updated: May 5, 2026

Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model
09:46

Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model

Published on: September 14, 2009

16.5K

在de novo冠状动脉病变中使用sirolimus和paclitaxel排泄的支架:REALITY试验:随机对照试验.

Marie-Claude Morice1, Antonio Colombo, Bernhard Meier

  • 1Institut Cardiovasculaire Paris Sud, Massy, France. mc.morice@icps.com.fr

JAMA
|February 24, 2006
PubMed
概括

这项研究发现,在新发冠状动脉病变的患者中,西罗利木斯排泄的支架和帕克利塔塞尔排泄的支架之间,在静脉缩或主要心脏不良事件中没有显著差异. 两种药物释放支架类型的安全性和疗效结果都相当.

更多相关视频

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

27.4K
Implantation of Human-Sized Coronary Stents into Rat Abdominal Aorta Using a Trans-Femoral Access
05:04

Implantation of Human-Sized Coronary Stents into Rat Abdominal Aorta Using a Trans-Femoral Access

Published on: November 19, 2020

4.0K

相关实验视频

Last Updated: May 5, 2026

Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model
09:46

Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model

Published on: September 14, 2009

16.5K
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

27.4K
Implantation of Human-Sized Coronary Stents into Rat Abdominal Aorta Using a Trans-Femoral Access
05:04

Implantation of Human-Sized Coronary Stents into Rat Abdominal Aorta Using a Trans-Femoral Access

Published on: November 19, 2020

4.0K

科学领域:

  • 心血管医学 心血管医学
  • 干预心脏病学 干预心脏病学
  • 生物医学工程 生物医学工程

背景情况:

  • 与裸金属支架相比,释放药物的支架 (sirolimus-eluting和paclitaxel-eluting) 改善了结果.
  • 没有前性多中心研究直接比较西罗利斯排泄和帕克利塔塞尔排泄的支架,用于新冠状动脉病变.

研究的目的:

  • 在患有新冠病变的患者中,比较 sirolimus-eluting 与 paclitaxel-eluting 冠状动脉支架的安全性和有效性.

主要方法:

  • 一项前性,随机的多中心试验 (REALITY) 涉及1386名新冠肺炎病变患者.
  • 患者被随机分配到接受一种西洛利木斯排泄的支架 (n=701) 或一种帕克利塔塞尔排泄的支架 (n=685).
  • 主要终点是8个月内损伤二进制复原;次要终点包括1年的主要不良心脏事件.

主要成果:

  • 在8个月内,在损伤中的二进制缩中没有显著差异 (9.6%对11.1%,P=.31).
  • 与帕克利塔塞尔输出支架相比,西罗利斯输出支架显示出明显较低的支架内迟损失和直径狭窄 (P<.001对于两者).
  • 在两种支架类型 (10.7%与11.4%,P=.73) 之间,主要心脏不良事件的一年率相似.

结论:

  • 在治疗新发冠状动脉病变时,sirolimus-eluting和paclitaxel-eluting冠状动脉支架的安全性和有效性相似.
  • 在1年后的二元静止率或主要不良心脏事件中没有观察到显著差异.